Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Clarke

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.
Breast Cancer Research and Treatment|October 2, 2014
Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcomeKatherine Drews-Elger, Elizabeth Iorns, Alexandra Dias, et al.
Nature Communications|July 12, 2019
Time series modeling of cell cycle exit identifies Brd4 dependent regulation of cerebellar neurogenesisClara Penas, Marie E Maloof, Vasileios Stathias, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouseMarco A Passini, Jie Bu, Jonathan A Fidler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
AAV gene therapy for GBA1-related diseasesSwathi Ayloo, Jae Cheon Ryu, Shih-Ching Chou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activityJames C Dodge, Amanda M Haidet, Wendy Yang, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Child Abuse & Neglect|September 19, 2024
Yield of skeletal surveys in national network of child abuse pediatricians: Age is keyCaitlin R McNamara, Joanne N Wood, Daniel Lindberg, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.
Breast Cancer Research and Treatment|October 2, 2014
Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcomeKatherine Drews-Elger, Elizabeth Iorns, Alexandra Dias, et al.
Nature Communications|July 12, 2019
Time series modeling of cell cycle exit identifies Brd4 dependent regulation of cerebellar neurogenesisClara Penas, Marie E Maloof, Vasileios Stathias, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouseMarco A Passini, Jie Bu, Jonathan A Fidler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
AAV gene therapy for GBA1-related diseasesSwathi Ayloo, Jae Cheon Ryu, Shih-Ching Chou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activityJames C Dodge, Amanda M Haidet, Wendy Yang, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Child Abuse & Neglect|September 19, 2024
Yield of skeletal surveys in national network of child abuse pediatricians: Age is keyCaitlin R McNamara, Joanne N Wood, Daniel Lindberg, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Pageof 14